CD4 and Cirrhosis: The reduced populations of effector CD4+ T cells and NK cells might impair the process of elimination of activated HSC cells or retained hepatocytes, potentially leading to progression of hepatic fibrosis to cirrhosis or hepatocellular carcinoma.